Option Care Health, Inc. (NASDAQ:OPCH) Expected to Announce Quarterly Sales of $919.82 Million

Wall Street brokerages forecast that Option Care Health, Inc. (NASDAQ:OPCH) will announce $919.82 million in sales for the current quarter, according to Zacks Investment Research. Five analysts have provided estimates for Option Care Health’s earnings, with the lowest sales estimate coming in at $905.30 million and the highest estimate coming in at $934.88 million. Option Care Health posted sales of $804.71 million during the same quarter last year, which indicates a positive year-over-year growth rate of 14.3%. The company is scheduled to issue its next quarterly earnings report on Thursday, March 10th.

On average, analysts expect that Option Care Health will report full year sales of $3.43 billion for the current year, with estimates ranging from $3.42 billion to $3.45 billion. For the next year, analysts forecast that the business will post sales of $3.71 billion, with estimates ranging from $3.69 billion to $3.74 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that follow Option Care Health.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Thursday, November 4th. The company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.01. Option Care Health had a return on equity of 7.86% and a net margin of 2.48%. The business had revenue of $891.94 million during the quarter, compared to analysts’ expectations of $886.47 million. During the same quarter last year, the business posted $0.01 EPS. The business’s revenue was up 14.1% on a year-over-year basis.

Several research firms have weighed in on OPCH. TheStreet upgraded Option Care Health from a “c+” rating to a “b” rating in a report on Thursday, December 9th. Deutsche Bank Aktiengesellschaft raised their target price on Option Care Health from $23.50 to $32.00 and gave the company a “buy” rating in a research note on Friday, November 5th. Finally, Zacks Investment Research cut Option Care Health from a “buy” rating to a “hold” rating in a research note on Friday. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $28.57.

NASDAQ OPCH traded down $0.44 on Friday, hitting $24.33. The company’s stock had a trading volume of 567,418 shares, compared to its average volume of 809,022. Option Care Health has a 52-week low of $16.02 and a 52-week high of $28.86. The company has a current ratio of 1.67, a quick ratio of 1.28 and a debt-to-equity ratio of 1.02. The company’s 50-day simple moving average is $26.55 and its 200 day simple moving average is $24.60. The firm has a market cap of $4.38 billion, a P/E ratio of 52.48 and a beta of 1.35.

In related news, COO Harriet Booker sold 6,000 shares of the firm’s stock in a transaction that occurred on Monday, December 6th. The stock was sold at an average price of $24.81, for a total transaction of $148,860.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In the last ninety days, insiders have sold 18,000 shares of company stock valued at $474,180. 47.00% of the stock is owned by corporate insiders.

Several institutional investors have recently bought and sold shares of the business. FMR LLC increased its holdings in shares of Option Care Health by 58.6% in the 2nd quarter. FMR LLC now owns 16,053,322 shares of the company’s stock worth $351,086,000 after purchasing an additional 5,933,454 shares in the last quarter. BlackRock Inc. increased its holdings in shares of Option Care Health by 105.9% in the 3rd quarter. BlackRock Inc. now owns 15,859,966 shares of the company’s stock worth $384,761,000 after purchasing an additional 8,157,744 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of Option Care Health by 21.8% in the 2nd quarter. Vanguard Group Inc. now owns 10,109,441 shares of the company’s stock worth $221,093,000 after purchasing an additional 1,807,802 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Option Care Health by 38.5% in the 2nd quarter. Price T Rowe Associates Inc. MD now owns 8,666,112 shares of the company’s stock worth $189,528,000 after purchasing an additional 2,408,728 shares in the last quarter. Finally, Park West Asset Management LLC increased its holdings in shares of Option Care Health by 0.3% in the 3rd quarter. Park West Asset Management LLC now owns 6,043,475 shares of the company’s stock worth $146,615,000 after purchasing an additional 15,710 shares in the last quarter. 95.99% of the stock is owned by institutional investors and hedge funds.

About Option Care Health

Option Care Health, Inc engages in the provision of home and alternate site infusion services. The firm involves in the clinical management of infusion therapy, nursing support, and care coordination. It also offers anti-infective, nutrition support, heart failure, chronic inflammatory disorders, immunoglobulin, bleeding disorders, women’s health, neurological disorders, and specialized therapies.

Featured Article: Compound Interest

Get a free copy of the Zacks research report on Option Care Health (OPCH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.